Clinical Trial Update: Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluates the combination of oxaliplatin and capecitabine in patients with relapsed or metastatic head and neck cancer and the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: University of Miami | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED